Winton Group’s IDEAYA Biosciences IDYA Stock Holding History

Winton Group’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-42,283	Closed	-$1.15M	–	1010
2025 Q3	$1.15M	Buy	+42,283	New	+$1.02M	0.04%	403

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Winton Group's IDYA Position: Q4 2025 in Review

Winton Group sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 42,283 shares — an estimated $1.15M sold.

Winton Group first reported a position in IDYA in Q3 2025 and held it in 1 quarter. The position peaked at $1.15M in Q3 2025. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

Winton Group reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
Winton Group sold 42,283 IDEAYA Biosciences shares in Q4 2025, an estimated $1.15M.
Winton Group first reported a position in IDEAYA Biosciences in Q3 2025 and held it in 1 quarter.
Winton Group's IDEAYA Biosciences position peaked at $1.15M in Q3 2025.
246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on Winton Group's 13F filing for Q4 2025, filed 11 Feb 2026.